Highlights
A collection of news and information related to Vivus Incorporated published by this site and its partners.
Displaying items 1-12 of 23
» View ky3.com items only
1
2
Next >
-
Novo obesity drug seen with 43 percent chance of approval
ReutersCOPENHAGEN (Reuters) - Danish group Novo Nordisk's diabetes drug Victoza has a 43 percent chance of being approved as an obesity treatment in the United States, according to a Reuters poll which found Danish bank analysts had the highest expectations....Tags: Obesity, Diabetes, Health, United Nations, Health Organizations
-
UPDATE 2-US FDA staff focus on safety of Arena obesity pill
Reuters* Obesity pill one of three vying for U.S. approval * Shares up 18 pct after FDA staff minimize cancer issues * FDA staff focus on heart safety * FDA panel to review drug on Thursday (Recasts with FDA documents, adds background) By Anna Yukhananov...Tags: Obesity, Meridia (drug), Diabetes, Orexigen Therapeutics, Inc., Health
-
UPDATE 3-US FDA staff focus on safety of Arena obesity pill
Reuters* Obesity pill one of three vying for U.S. approval * Shares up 14 pct after FDA staff minimize cancer issues * FDA staff focus on heart safety * FDA expert panel to review drug on Thursday (Adds FDA comment, more details from FDA review, updates...Tags: Obesity, Meridia (drug), Orexigen Therapeutics, Inc., Diabetes, Health
-
FDA approves Vivus drug for erectile dysfunction
ReutersWASHINGTON, April 27 (Reuters) - U.S. health regulators on Friday approved Vivus Inc.'s avanafil treatment for erectile dysfunction, giving the small company, which has struggled to bring a weight loss drug to market, a potentially lucrative commercial...Tags: Food and Drug Administration, Erectile Dysfunction, Viagra (drug), Pfizer Inc.
-
FDA approves new erectile dysfunction pill Stendra
The U.S. Food and Drug Administrationapproved Stendra, a new drug to treat erectile dysfunction in men, on Friday. Like Viagra, Cialis and Levitra, Stendra (generic name avanafil) is a pill, and is in a class of drugs called PDE5 inhibitors. These work...
Tags: Cialis (drug), High Blood Pressure, Levitra (drug), Health, Food and Drug Administration
-
UPDATE 1-FDA approves Vivus drug for erectile dysfunction
Reuters* Drug to be sold under brand name Stendra * Belongs to same class as Viagra, Cialis and Levitra * Awaiting European approval decision * Vivus shares halted (Adds FDA comment, background) WASHINGTON, April 27 (Reuters) - U.S. health regulators on...Tags: Back Pain, High Blood Pressure, Levitra (drug), Health, GlaxoSmithKline PLC
-
REUTERS AMERICA NEWS BUDGET - FRIDAY, APRIL 27, P.M.
Reuters(** = New/Updated) UNITED STATES: ** NEW YORK - Space shuttle Enterprise lands in New York atop jet (SHUTTLE-ENTERPRISE/NEWYORK (UPDATE 2, PIX, TV), moved, 500 words) ** WASHINGTON - Obama administration pulls rule on child farm labor (USA-FARMS/...Tags: Arts and Culture, Justice System, Elections, Republican Party, Technology
-
UPDATE 2-FDA approves Vivus's fast-acting Viagra rival
Reuters* Drug to be sold under brand name Stendra * Belongs to same class as Viagra, Cialis and Levitra * Awaiting European approval * Vivus shares rise 3 percent (Recasts first paragraph, adds share move, doctor, analyst comment, changes dateline) By...Tags: Back Pain, Obesity, High Blood Pressure, Levitra (drug), Health
-
REUTERS AMERICA NEWS BUDGET - SATURDAY, APRIL 28, P.M.
Reuters(** = New/Updated) UNITED STATES: ** BEIJING - Escaped China activist in US protection-rights group (CHINA-USA/DISSIDENT (UPDATE 11, PIX, TV), moved, 1400 words, may be led) ** WASHINGTON - Clinton, Geithner Beijing trip going ahead -source (CHINA-...Tags: Cairo (Egypt), Arts and Culture, Ray Charles, Bill Clinton, Movies
-
FDA approves Vivus's fast-acting Viagra rival
ReutersNEW YORK (Reuters) - Men with erectile dysfunction may not have to plan for sex as far in advance anymore after Vivus Inc won U.S. approval for avanafil, its faster acting rival to Viagra. Avanafil, which will be sold under the brand name Stendra, is the...Tags: Back Pain, Obesity, High Blood Pressure, Health, Levitra (drug)
-
Nuevo rival para el Viagra
Los hombres con disfunción eréctil quizás no tengan que volver a hacer planes adelantados para tener relaciones sexuales, luego de que Vivus Inc. ganara la aprobación en Estados Unidos de su producto Avanafil, que viene a competir con Viagra, de Pfizer...Tags: Lilly Eli & Co, Cialis (drug), Levitra (drug), Health, GlaxoSmithKline PLC
-
U.S. RESEARCH ROUND-UP: Apple, 3M, AT&T
ReutersApril 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Apple, Ford Motor, Regions Financial and RadioShack, on Wednesday. HIGHLIGHTS * Apple : Brokerages lift target price after...Tags: Lennox International Incorporated, OSI Systems Incorporated, Apple iPhone, SunTrust Banks Incorporated, Kindred Healthcare Incorporated
May 24, 2012
|Story| Reuters
May 8, 2012
|Story| Reuters
May 8, 2012
|Story| Reuters
Apr 27, 2012
|Story| Reuters
Apr 27, 2012
|Story| Los Angeles Times
Apr 27, 2012
|Story| Reuters
Apr 27, 2012
|Story| Reuters
Apr 27, 2012
|Story| Reuters
Apr 28, 2012
|Story| Reuters
Apr 27, 2012
|Story| Reuters
Apr 30, 2012
|Story| South Florida Sun-Sentinel
Apr 25, 2012
|Story| Reuters
Original site for Vivus Incorporated topic gallery.